Open AccessBiologically active orcinol-based secondary metabolites originated from lichens
Author(s) -
Boddu Rama Krishna,
Narayana Rao Gundoju,
Tiruveedhula Somasekhar,
Waill A. Elkhateeb,
Ghoson M. Daba
Publication year - 2022
Publication title -
nova biotechnologica et chimica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.212
H-Index - 9
eISSN - 1339-004X
pISSN - 1338-6905
DOI - 10.36547/nbc.1075
Subject(s) - orcinol , lichen , anthraquinones , chemistry , antifungal , phytochemistry , secondary metabolite , biological activity , usnic acid , botany , environmental chemistry , organic chemistry , biochemistry , biology , microbiology and biotechnology , in vitro , gene
Lichens have attracted considerable interest since ancient time due to their medicinal properties. Lichen produce a variety of orcinol-based compounds such as xanthones, anthraquinones, dibenzofurans, depsides, and depsidones. Several related compounds have shown potent bioactivities as antiviral, antioxidant, anti-herbivore, insecticidal, antifungal, and anticancer. Lichens have been employed as traditional medicines, and these are continuing to be of great interest for their biotechnological potential. The purpose of this review was to systematically evaluate the literature on the orcinol based biologically active secondary metabolites of lichen.